This announcement is a separate document:
兴齐眼药：关于硫酸阿托品滴眼液（0.02%0.04%）延缓儿童近视进展的临床试验取得Ⅲ期临床试验总结报告的提示性公告
Sinqi Pharmaceutical: An indicative announcement on the clinical trial of atropine sulphate eye drops (0.02% 0.04%) to slow the progression of myopia in children obtained a phase III clinical trial summary report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated